Catalyst Wire Dossier Catalyst Wire Dossier

ketorolac ophthalmic solution 0.4%

ketorolac tromethamine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ketorolac ophthalmic solution 0.4%, covering 2007-07-13 to 2007-07-13. Get the full timeline:

Most recent: Clinical Trial Update: Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients [Phase 4]

See pricing